A Study to Learn How Different Amounts of the Study Medicine Called PF-07999415 are Tolerated and Act in the Body in Healthy Adults
This early-stage clinical trial is testing a new medicine named PF-07999415 in humans for the very first time. The study aims to find out how safe the medicine is, what side effects it might cause, and how healthy bodies process it. Because this is a Phase 1 trial, it involves healthy adult volunteers rather than people with a specific illness. Participants will receive carefully measured amounts of the study medicine while doctors monitor them closely. The medical team will check blood pressure, heart rhythms, and take blood and urine samples to see how the drug is absorbed and cleared. Volunteers will not receive any direct medical benefit from the drug, but their help allows scientists to work out safe doses for future research. Taking part is completely voluntary, and volunteers can leave the study at any time.
At a glance
What is this study about?
Every new medicine must go through several testing stages before it can be prescribed to patients. This study is a 'first-in-human' trial for an experimental medicine called PF-07999415. This means it is the first time this particular drug is being given to people, following laboratory and safety checks in the lab.
The main goal of the trial is to see how the human body reacts to different doses of the medicine. Doctors want to confirm that it is safe, identify any side effects, and see how well healthy people tolerate it. They will also measure how quickly the medicine enters the bloodstream, how it travels through the body, and how it is broken down and removed.
Trials like this are essential building blocks for modern medicine. By testing the drug in a small group of closely watched healthy volunteers, researchers can gather the safety facts they need. This knowledge helps them decide if the treatment should move forward into larger studies for people with medical conditions.
Key takeaways
- This is a Phase 1 study testing the medicine PF-07999415 in humans for the first time.
- The main aim is to check safety and see how the body handles different doses.
- The study is looking for healthy adult volunteers aged 18 and older.
- Participants will need to undergo health tests and clinic visits for close monitoring.
- Joining is completely voluntary, and you can withdraw at any time.
Who may be eligible?
This trial is open to healthy adults aged 18 and older. Both men and women may be able to join. Because the study focuses on basic safety, researchers need volunteers who do not have major ongoing medical conditions.
To take part, volunteers will need to pass health checks to ensure their heart, liver, and kidneys are working well. People who take certain regular prescription medications, have a history of serious illness, or use recreational drugs are usually not able to join.
Women who are pregnant, planning to become pregnant, or breastfeeding cannot take part. Volunteers may also need to agree to use reliable contraception during the study to prevent any potential risk to an unborn child.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- I am aged 18 or older.
- I consider myself to be in good overall health.
- I am not currently taking regular prescription medications (or willing to discuss them).
- I am not pregnant, planning a pregnancy, or breastfeeding.
- I am willing and able to spend time at a clinic for tests and monitoring.
What does participation involve?
Taking part usually involves visiting a specialist clinical research unit. Before anything begins, you will attend a screening visit where doctors check your medical history and carry out standard tests, such as blood tests, urine tests, and heart traces (ECGs). If you are accepted, you will receive a dose of the study medicine. You may need to stay overnight in the clinic for close monitoring, followed by several return visits over a few weeks. The medical team will take regular blood and urine samples and check your vital signs to track the medicine. The total time commitment can range from a few weeks to a couple of months, and the team will explain the exact schedule before you agree to join.
Potential risks and benefits
Locations (1)
- —UnverifiedBelgium
Common questions
What is a Phase 1 clinical trial?
A Phase 1 trial is the earliest phase of human testing. It focuses on safety, side effects, and how the body handles the medicine, rather than treating an illness.
Will I be paid for taking part?
Phase 1 trials involving healthy volunteers usually offer financial compensation for your time, travel, and inconvenience. The study team will provide details during screening.
Can I leave the study if I change my mind?
Yes. You can withdraw your consent and leave the study at any point, and you do not have to give a reason.
How is the study medicine given?
Depending on the study design, it might be given as a tablet to swallow or as an injection or drip into a vein. The study team will confirm the method.
What happens if I feel unwell during the trial?
Doctors and nurses are present throughout the study to look after you. If you feel unwell, they will assess you immediately and provide any needed care.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.